Tullman has built a lifestyle of giving back at Allscripts personally, both by providing opportunities for employee philanthropy and through his personal actions and the actions of his Base. It’s an honor to simply accept this prestigious award from the nation’s health care CIOs, Mr. Tullman stated. I talk about CHIME’s appreciation of the need for the collaboration and exchange of information between sector leaders, which plays a part in effective improvements to our healthcare system. Bill Spooner, Chief Details Officer of Sharp Health care and a former person in CHIME’s Panel of Trustees, wrote in a letter supporting Mr. Tullman’s nomination, Through Glen’s visionary leadership, he has generated a company with product offerings over the community of care.In the LITHE study, Actemra was generally well tolerated and the overall safety profile after 12 weeks of treatment was consistent with previously reported 6 month trial data. The results of the study is good news for RA individuals as presently many either fail to achieve a satisfactory response or cannot tolerate therapies currently available. New treatment options are needed, particularly the ones that can focus on different pathways to bring alleviation and inhibit joint damage in patients experiencing RA.